Get access

Development of a novel ovarian cancer molecular target therapy against cancer-related transcriptional factor, NAC1

Authors


Dr Kentaro Nakayama, Department of Obstetrics and Gynecology, Shimane University School of Medicine, 89-1 Enyacho, Izumo, Shimane 693-8501, Japan. Email: kn88@med.shimane-u.ac.jp

Ancillary